{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "exchange": "ASX", "shortName": "ARGENICA FPO", "longName": "Argenica Therapeutics Limited", "messageBoardId": "finmb_712463731", "exchangeTimezoneName": "Australia/Sydney", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "market": "au_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.42, "marketState": "POSTPOST", "firstTradeDateMilliseconds": 1623369600000, "priceHint": 4, "epsTrailingTwelveMonths": -0.05, "sharesOutstanding": 86922200, "bookValue": 0.08, "fiftyDayAverage": 0.42705, "fiftyDayAverageChange": -0.0070500076, "fiftyDayAverageChangePercent": -0.016508624, "twoHundredDayAverage": 0.47045, "twoHundredDayAverageChange": -0.050450027, "twoHundredDayAverageChangePercent": -0.10723781, "marketCap": 36507324, "priceToBook": 5.25, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "ipoExpectedDate": "2021-06-11", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.0, "regularMarketTime": 1683849722, "regularMarketDayHigh": 0.42, "regularMarketDayRange": "0.42 - 0.42", "regularMarketDayLow": 0.42, "regularMarketVolume": 4979, "regularMarketPreviousClose": 0.42, "bid": 0.41, "ask": 0.44, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 0.42, "averageDailyVolume3Month": 37380, "averageDailyVolume10Day": 33040, "fiftyTwoWeekLowChange": 0.06999999, "fiftyTwoWeekLowChangePercent": 0.19999999, "fiftyTwoWeekRange": "0.35 - 0.695", "fiftyTwoWeekHighChange": -0.275, "fiftyTwoWeekHighChangePercent": -0.39568347, "fiftyTwoWeekLow": 0.35, "fiftyTwoWeekHigh": 0.695, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "AGN.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "117 Broadway", "address2": "Unit 4", "city": "Nedlands", "state": "WA", "zip": "6009", "country": "Australia", "phone": "61 8 9329 3396", "website": "https://argenica.com.au", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Argenica Therapeutics Limited engages in the research and development of a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate use to protect brain cells and reduce cell death during a stroke and other types of neural injuries. The company was incorporated in 2019 and is based in Nedlands, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Liz  Dallimore B.Sc., M.B.A., Ph.D.", "title": "CEO, MD & Director", "fiscalYear": 2022, "totalPay": {"raw": 250250, "fmt": "250.25k", "longFmt": "250,250"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 162500, "fmt": "162.5k", "longFmt": "162,500"}}, {"maxAge": 1, "name": "Dr. Samantha  South GAICD, MBA, Ph.D.", "title": "COO & Exec. Director", "fiscalYear": 2022, "totalPay": {"raw": 198000, "fmt": "198k", "longFmt": "198,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 65000, "fmt": "65k", "longFmt": "65,000"}}, {"maxAge": 1, "name": "Ms. Emma  Waldon", "age": 46, "title": "CFO & Company Sec.", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Bruno Philip Meloni", "title": "Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Meghan  Thomas", "title": "Head of Clinical Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}